INTRODUCTION
Fructoaldolases (EC 4.1.2.13) catalyse the specific and reversible cleavage of fructose 1,6-bisphosphate (FBP) and fructose 1-phosphate (F1P) into dihydroxyacetone phosphate and -glyceraldehyde 3-phosphate or -glyceraldehyde respectively. In vertebrates there are three genetically distinct aldolase isoenzymes, each with a distinct expression pattern : aldolase A is predominant in muscle, aldolase B in liver, kidney and small intestine, and aldolase C in the brain. Aldolases A and C are expressed constitutively, whereas the B isoenzyme is under dietary control. All the functional enzymes are homotetramers of approx. 160 kDa [1] .
In humans, aldolase B deficiency causes hereditary fructose intolerance (HFI), a recessively inherited disorder of carbohydrate metabolism whose frequency is estimated to be 1 in 20 000 live births [2] . The human aldolase B gene is 14,500 bp long ; it consists of nine exons and encodes a 364-residue polypeptide (type B monomer). So far, 23 mutations have been identified in the aldolase B gene of patients affected by HFI [3] . They include mis-sense and nonsense mutations, large and small deletions and mutations in the splicing regions. The most common HFI mutations in Europe are Ala"%* Pro and Ala"(% Asp in exon 5, and Asn$$% Lys in exon 9. The other mutations are spread throughout the entire aldolase B gene ; their frequencies differ between ethnic groups [3] .
In recent years we have investigated the aldolase B gene of patients with clinical HFI symptoms and identified, in addition to known molecular defects, three novel disease-causing mutations [4] [5] [6] . We now describe a novel HFI mutation at 1 These authors contributed equally to the work. 2 To whom correspondence should be addressed (e-mail salvator!unina.it).
wild-type, Trp$!$ and Gln$!$ aldolase B generated by homologymodelling techniques suggest that, because of its larger size, tryptophan exerts a greater deranging effect than glutamine on the enzyme's three-dimensional structure. Our results show that the Arg$!$ Gln substitution is a novel mutation causing hereditary fructose intolerance and provide a functional demonstration that Arg$!$, a conserved residue in all vertebrate aldolases, has a dominant role in substrate binding during enzyme catalysis.
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Arg$!$ (Arg$!$ Gln) in the aldolase B gene. We have analysed the kinetic properties of the wild-type and of the aldolase B variants (Arg$!$ Gln and Arg$!$ Trp) and the functional effects of these mutations on protein folding and structure. The kinetic parameters obtained reflect the altered molecular structures derived by homology-modelling techniques.
EXPERIMENTAL Materials
Restriction endonucleases were purchased from New England Biolabs. Taq polymerase, T4 DNA ligase, isopropyl β--thiogalactoside (IPTG), ampicillin, PMSF and α-glycerol-phosphate dehydrogenase\triose phosphate isomerase (GDH\TIM) were purchased from Roche Molecular Biochemicals. Imidazole, FBP, F1P and NADH were purchased from Sigma-Aldrich. The pET-16b vector and the Escherichia coli strains BL21(DE3) were purchased from Novagen.
The patient
The proband is an Italian infant girl in whom HFI was suspected because of clinical symptoms and liver failure after the administration of sucrose-containing medicine during a feverish episode. Both parents are healthy.
DNA analysis
Genomic DNA was purified from peripheral blood leucocytes by the NaCl extraction method [7] . The whole aldolase B coding region, the splice junctions and the promoter region were amplified by PCR as described previously [4] [5] [6] . The amplified DNA fragments were analysed by single-strand conformation polymorphism analysis and sequenced with the Sequenase PCR Product Sequencing Kit (Amersham Pharmacia Biotech), in accordance with the manufacturer's instructions. For Mendelian inheritance analysis of the Arg$!$ Gln mutation in the proband's family, the amplified DNA samples corresponding to exon 8 were digested with ApaI at 30 mC and the products were separated on 2 % (w\v) agarose gel.
Cloning of PCR-amplified cDNA
The full-length wild-type human aldolase B cDNA, previously cloned in the prokaryotic pAT153 vector [8] , was amplified by using primers that had an extension of 10 nt containing the NdeI site at the 5h end (plus primer, 5h-GGAATTCCATATGGCCC-ACCGATTTCCAGCC-3h) and the aldolase B termination codon TAG followed by a XhoI restriction site at the 3h end (minus primer, 5h-GGAATTCCTCGAGCTAGTAGGTATAG-CAGGC-3h). The cDNA sequence was verified by automated sequencing. The amplified cDNA was cloned into the NdeI and XhoI sites of the bacterial expression vector pET-16b, downstream from a His-tag coding sequence. To select recombinant clones, E. coli XL1-Blu host cells were transformed with a vector containing the target gene. Recombinant plasmid (pET-16b\ cDNA) was purified over a Qiagen column (Qiagen).
Site-directed mutagenesis
The QuickChange2 site-directed mutagenesis kit (Stratagene) was used to introduce mutations into the pET-16b\cDNA construct. Mutagenesis reactions were performed with a PerkinElmer 9600 thermal cycler. To change the normal Arg$!$ into a Gln residue, primers 5h-GTTTCTCTTATGGACAGGCCCTG-CAGGC-3h (sense) and 5h-GCCTGCAGGGCCTGTCCATAA-GAGAAAC-3h (anti-sense) were designed. To change Arg$!$ into a Trp residue, the sense primer was 5h-GTTTCTCTTATG-GATGGGCCCTGCAGGC-3h and the anti-sense primer was 5h-GCCTGCAGGGCCCATCCATAAGAGAAAC-3h. After treatment with DpnI to digest the parental methylated DNA, the newly synthesized DNA was used to transform the E. coli XL1-Blu competent cells in accordance with the manufacturer's instructions. We selected mutated clones by PCR and direct sequencing. Recombinant mutated plasmids, pET-16b\Gln$!$ and pET-16b\Trp$!$, were purified over a Qiagen column and their full sequences were verified by automated sequencing.
Expression and purification of the recombinant enzymes
Normal and mutated recombinant plasmids (pET-16b\cDNA, pET-16b\Gln$!$ and pET-16b\Trp$!$) were separately transformed into the host E. coli B strain BL21(DE3) and grown to mid-exponential phase at 37 mC in Luria-Bertani medium supplemented with 100 µg\ml ampicillin. Expression of the corresponding proteins was induced with 1 mM IPTG. After a further 3 h of growth at 37 mC, harvested cells (approx. 1.5 g) were lysed by sonication in 10 ml of a non-denaturant lysis buffer [20 mM imidazole\300 mM NaCl\50 mM NaH # PO % ] containing PMSF (1 mM). Lysates were centrifuged for 30 min at 10 000 g ; soluble fractions, containing the recombinant His-tagged proteins, were mixed with 1 ml of Ni\nitrilotriacetate resin (Qiagen) for 1 h at 4 mC. The lysate\resin mixtures were loaded on a column and the flow-through was collected. The resin binding the His-tagged protein was washed twice with 4 ml of washing buffer [50 mM imidazole\300 mM NaCl\50 mM NaH # PO % ] ; the recombinant aldolase B was eluted in eight fractions (0.5 ml each) with elution buffer [250 mM imidazole\300 mM NaCl\50 mM NaH # PO % ]. The collected fractions were analysed by SDS\PAGE [10 % (w\v) gel] and those containing the bulk of the enzyme were pooled, dialysed against 20 mM Tris\HCl, pH 7.5, containing 50 % (v\v) glycerol, then stored at k20 mC. All purification steps were performed at 4 mC.
Aldolase B activity assays and kinetic studies
The substrate cleavage rate was determined spectrophotometrically by measuring NADH oxidation at 340 nm and 30 mC in a coupled assay with GDH\TIM and FBP or F1P as substrates [9] . Activity assays were conducted in a final volume of 1 ml containing aldolase recombinant protein, appropriate substrate concentrations, 0.2 mM NADH, 0.5 mM EDTA, 100 mM Tris\ HCl, pH 7.5, and 10 µg\ml GDH\TIM. One unit of activity corresponds to the cleavage of 1 µmol of hexose substrate\min. Kinetic measures were performed in triplicate and K m and k cat values were calculated from double-reciprocal plots with the use of a least-squares method.
Protein characterization
Enzyme molecular masses were determined at 25 mC by cofractionation (on FPLC) of the purified proteins with β-amylase (200 kDa), chicken ovalbumin (44 kDa) and carbonic anhydrase (29 kDa) on a 50 cmi1.6 cm column of Sephadex G-200 (Amersham-Pharmacia Biotech) in 20 mM Tris\HCl, pH 7.4, with a flow rate of 0.2 ml\min. CD spectra were recorded at 25 mC with a protein concentration of 10 µM in a 10 mM phosphate buffer, pH 7.4, containing 10 % (v\v) glycerol, with a JASCO J-710A spectropolarimeter equipped with a cuvette with a 0.1 cm path length. Spectra were read from 190 to 260 nm ; the reading was averaged for 5 s at each 1 nm increment.
Structural analysis
The human aldolase B structure was modelled with the X-ray crystal structure of human aldolase A (Protein Data Bank code 4ald) as the starting model [10] . There is a high sequence identity (69 %) between the two isoenzymes ; there are neither deletions nor insertions and the sequence between Leu#*( and Leu$"! is identical. Hence this approach is highly reliable. Because the mutation site is far from any inter-subunit interface of the aldolase A tetramer, a single subunit of aldolase B was generated. The molecular graphics program O [11] was used to construct the aldolase B model. The energy of this model was subsequently minimized with the X-PLOR program [12] . With the same procedure, two other models of aldolase B were built with a Gln residue and a Trp residue in position 303.
RESULTS

DNA mutation analysis
The proband's aldolase B gene was analysed by single-strand conformation polymorphism analysis and direct sequencing. We have found only one alteration in exon 8 on only one allele with respect to the normal gene sequence, i.e. a G A substitution at nt 11125, which changes the normal Arg$!$ into a Gln residue ( Figure 1A ). We next sequenced the entire coding region and splice junctions to look for other mutations in the proband's aldolase B gene. No other nucleotide change was identified and we diagnosed the subject as a carrier of this novel Arg$!$ Gln mutation. This mutation abolishes an ApaI site in exon 8 ; we were thus able to follow the Mendelian transmission of the mutation in the proband's pedigree. Figure 1(B) shows that the proband inherited the Arg$!$ Gln mutation from her mother. The ApaI digestion of 70 chromosomes excluded the presence of the mutation in the normal population.
Expression and purification of recombinant aldolase B
To verify that the Arg$!$ Gln mutation can cause HFI, we performed site-directed mutagenesis to produce the correspond- ing mutated aldolase B and to analyse its functional properties. We set up the conditions to express human aldolase B in a bacterial expression system, permitting the rapid purification of recombinant proteins under native conditions. Next we compared the activities and kinetic behaviour of the normal and mutant enzymes. We cloned aldolase B cDNA in the expression vector pET-16b, downstream from a His-tag sequence. The presence of a hexahistidine ' head ' does not alter the structural or functional characteristics of aldolase B, compared with the purified liver enzyme [13] . Mutations Arg$!$ Gln and Arg$!$ Trp were introduced into the recombinant pET-16b\cDNA plasmid by site-directed mutagenesis. The recombinant His-tagged proteins, expressed in E. coli strain BL21(DE3), were recovered from the soluble fraction of the bacterial lysate and purified. The purification was checked to be more than 95 % by SDS\PAGE (Figure 2 ). The level of expression was 10-15 mg\l of culture for the wild-type and mutated enzymes. CD spectra of wild-type, Gln$!$ and Trp$!$ recombinant aldolases revealed nearly identical curves within experimental error, suggesting that the three enzymes share very similar secondary structures (Figure 3a) . Moreover, the spectra were very similar to those published by Doyle and Tolan [13] : indeed, the mutations did not cause major perturbations in the enzyme secondary structure. Furthermore, the molecular mass of the recombinant enzymes, determined by FPLC, was approx. 170 kDa, in accord with the homotetrameric structure expected for His-tagged aldolase B after purification under native conditions (Figure 3b ).
Kinetic analyses of normal, Arg 303
Gln and Arg 303 
Trp recombinant aldolase B
Next we determined the kinetic parameters of the three recombinant enzymes (Table 1 ). The recombinant wild-type aldolase B (rec WT) had a specific activity and K m values for substrates FBP and F1P similar to those reported for aldolase B purified from human liver [13] .
The recombinant Gln$!$ aldolase B (rec Gln$!$) had a specific activity for FBP of 0.47 unit\mg, i.e. approx. 50 % of that of rec WT. Its K m was approx. 60-fold the normal value and its specific activity towards F1P was 24 % (0.25 units\mg) and the K m was approx. 25-fold that of rec WT.
The specific activity of the recombinant Trp$!$ aldolase B (rec Trp$!$) was approx. 10 % of that of the wild-type for FBP (0.10 unit\mg compared with 0.9 unit\mg). A higher FBP concentration was required to determine the K m of rec Trp$!$ ; K m is therefore expressed in mM rather than in µM, at variance with the other recombinant proteins (rec WT and rec Gln$!$) ; the specific activity of rec Trp$!$ for F1P was not measurable.
Although specific activity results suggest that the Arg$!$ Gln substitution had a greater effect on F1P cleavage than on FBP cleavage, substrate affinity decreased more for FBP than for F1P. In both cases k cat \K m was approx. 1\100 of normal, indicating that the Gln$!$ mutation modified FBP and F1P cleavage to about the same extent.
In contrast, the Trp$!$ mutant kinetic study showed that the cleavage of FBP was affected less than cleavage of the specific enzyme substrate F1P. K m was measurable only for FBP and it was higher than the K m determined for the Gln$!$ mutant towards the same substrate. Thus it seems that the Arg$!$ Trp substitution has a greater effect than Arg$!$ Gln on aldolase B functionality.
Structural analysis
So far there have been no reports of the experimentally derived structure of aldolase B. To establish the structural variations in the three-dimensional structure of the enzyme induced by the mutations, we constructed a model for wild-type, Gln$!$ and Trp$!$ aldolase B by using homology-modelling techniques. As expected on the basis of the high similarity between the two enzymes, the secondary structure elements and the overall folding of aldolase A were preserved in aldolase B (Figure 4a ). In fact, the root-mean-square deviation of the corresponding backbone (N, C α , C, O) atoms of the two structures was 0.59 A / . It is noteworthy that the Arg$!$ side chain presented a different orientation owing to the proximity in aldolase B of the side chain of Arg%& (Ser in aldolase A). This indicated a rather high flexibility of the Arg$!$ side chain. The analysis of the unbound aldolase B models carrying the Arg$!$ mutations showed that the side chain of a Gln residue and of a Trp residue could be accommodated at this position with minor modifications of the local structure of the protein. Comparison of these two mutant models with the structure of aldolase A complexed with FBP [10] reveals that the bulky Trp side chain occupied the 1-phosphatebinding site (Figure 4b ), whereas the smaller side chain of the Gln residue, located in approximately the same region, left the 1-phosphate site more available for binding of the substrate (Figure 4c ).
DISCUSSION
The molecular diagnosis performed in two subjects suspected of having HFI led us to identify two distinct aldolase B mutations at the level of residue Arg$!$. In a first study we identified a point mutation that transformed Arg$!$ into Trp [5] . In the patient, who was homozygous for the mutation, aldolase B activity was not detectable in liver biopsy with either enzyme substrate. In the present study we analysed the aldolase B gene of an infant girl in whom HFI was suspected and we highlighted a nucleotide substitution that replaced Arg$!$ with a Glu residue. No other mutations were found in the gene, so that the subject was diagnosed as a carrier of HFI ; the molecular diagnosis was confirmed by a subsequent fructose challenge.
The aim of this study was to shed light on how these two naturally occurring substitutions in the critical Arg$!$ residue of aldolase B affect the enzyme function, and if structural models can explain differences in their function.
We obtained the mis-sense aldolase B variants corresponding to the Arg$!$ Gln and Arg$!$ Trp substitutions by sitedirected mutagenesis and expression in a prokaryotic host. The functional assays of rec Gln$!$ showed a residual activity for both substrates tested. Enzyme catalytic efficiencies (k cat \K m ) indicated a decrease to 1\100 compared with the wild-type enzyme for both substrates.
The rec Trp$!$ protein is inactive towards the specific substrate F1P, with a low residual activity towards FBP : the catalytic efficiency towards the latter substrate is approx. 4800-fold lower than wild-type. This result is consistent with the lack of aldolase B activity in liver biopsy samples from a patient with HFI homozygous for the mutation Arg$!$ Trp [5] . Therefore functional parameters have demonstrated that two natural mis-sense mutations in aldolase B at Arg$!$ severely affect the enzyme's catalytic efficiency towards both its substrates, and that replacement with a tryptophan residue impairs the enzyme function to a greater extent than that with a glutamine residue. Furthermore, we demonstrate that the deleterious effects exerted on enzyme functionality occur with the aldolase-Bspecific substrate F1P, thus explaining the HFI phenotype.
Arg$!$ is located on the α-helix that precedes the C-terminal tail ; several crystal structures determined over the years have added new insights into its role in the catalysis of class I aldolases. First, a refinement of the structure of human aldolase A at a resolution of 2.0 A / showed Arg$!$ to be near the active site [14] . In the crystal structure of rabbit aldolase A determined by Blom and Sygush [15] , a molecule of dihydroxyacetone phosphate, the product of the reaction, was bound to two subunits of the tetramer. This structure revealed that the Arg$!$ main chain is close to the 1-phosphate site. In addition, the Arg$!$ side chain adopts different conformations : indeed, in one subunit, Arg$!$ forms a salt bridge with Glu$&%. Consequently, on the basis of this finding, Arg$!$ was implicated in the pathway of product release [15] . Furthermore, the structure of aldolase A complexed with FBP confirmed that the Arg$!$ backbone nitrogen atom forms a hydrogen bond with one of the oxygens of the 1-phosphate group [10] : no interaction of the Arg$!$ side chain with the substrate was found. In contrast, the structure of the complex of the aldolase A mutant Lys"%' Ala with FBP, although confirming that Arg$!$ backbone is close to the 1-phosphate site, shows that the Arg$!$ side chain interacts with the 6-phosphate site [16] .
To explain the kinetics of the recombinant proteins, which indicate Arg$!$ to be an important residue for substrate binding, we extrapolated the known structure of aldolase A to aldolase B and constructed a three-dimensional model of aldolase B by using homology-modelling techniques. Before analysing these data, it is worth recalling that other aldolase B gene mutations lead to changes in the V max and K m of the enzymes for both its substrates [2] . Regardless of the mutation that causes the disease, such changes resemble those observed in the present study. The overall picture emerging from the homology-modelling technique indicates that the secondary structure elements and the whole architecture of the active site, including Arg$!$, are conserved ; particularly striking is the local sequence identity from Leu#*( to Leu$"!, even though some structural variations have been observed. In fact, our aldolase B model shows that the proximity of the positively charged Arg%& (a Ser in aldolase A) to Arg$!$ can restrict its conformational freedom. As a result, the binding of the negatively charged substrates in aldolases A and B might be different. This observation is supported by the analysis of the aldolase isoenzyme sequences. Arg%& is a conserved residue in aldolase B from various species, whereas it is Ser in aldolase A and Gln in aldolase C ; both exhibit different substrate specificities. It is noteworthy that in the aldolase B sequence, the residue in position 354 is Gln. Consequently, the strong salt bridge between Arg$!$ and Glu$&% observed in aldolase A cannot be formed in aldolase B, a finding that does not corroborate the role of Arg$!$ in the release of the reaction products [15] . In principle, the different substrate specificity of aldolases A and B could be invoked to postulate that Arg$!$ might have a different role in the two isoenzymes. However, this possibility is weakened by the observation that residue 354 is Gln also in aldolase C, which is endowed with the same substrate specificity as aldolase A.
Computer-generated models representing Gln$!$ and Trp$!$ aldolase B yield interesting insights into the structural bases of their altered functionality. Because we recovered the recombinant mutated enzymes as native tetramers at physiological temperature (37 mC), it is difficult to attribute the observed functional impairment to folding alterations that provoke changes in their quaternary structure.
In fact, in both cases the new side chains can be accommodated in the three-dimensional model of the unbound enzyme with minor structural alterations. However, owing to the vicinity of residue 303 to the active site, the Trp side chain hinders 1-phosphate binding. Therefore it is not surprising that the activity of the Trp$!$ mutant towards F1P is not detectable. In contrast, the residual (but significant) activity exhibited by Trp$!$ towards FBP can be explained by assuming that the 6-phosphate binding site acts as the anchoring point of the substrate.
Because of the smaller steric hindrance of 1-phosphate site in the Gln$!$ enzyme, the significant increase in the K m of the mutant towards both substrates demonstrates that the positively charged side chain of the arginine residue is important for the correct binding of the substrate. It is noteworthy that K m increases more for FBP (64-fold) than for F1P (26-fold).
The experiments on substrate binding alterations based on the kinetics of the purified recombinant enzymes demonstrate that the mutated proteins are indeed less active than the native counterpart (see Table 1 ). This is borne out by a body of evidence. Choi et al. [16] , for example, demonstrated for the Lys"%' Ala aldolase A mutant that Arg$!$ interacts with C-6-phosphate and with the sugar carbonyl group of FBP. Transformation of Arg$!$ to Ala by site-directed mutagenesis in aldolase A and determination of the kinetic constants of this mutant showed that the Arg$!$ Ala mutation has a con- siderable effect on the K m for FBP and for F1P. This effect is comparable to similar mutations at other residues implicated in binding, e.g. Lys"!( Ala and Arg"%) Ala [17] , strongly suggesting that Arg$!$ also has a critical role in substrate binding of aldolase A.
It is noteworthy that the decrease in k cat \K m for FBP observed for Gln$!$ and Trp$!$ aldolase B goes in the same direction as that for the Ala$!$ aldolase A mutant analysed by Choi et al. [16] . The conclusion is that Arg$!$ has a critical role in the substrate binding of both aldolase A or aldolase B. The high sequence similarity between the two isoenzymes in this region supports the conclusion.
